MedWatch

Demant forecasts better 2021 than pre-corona and hacker attack

After two particularly grueling years for Danish hearing aid company Demant, CEO Søren Nielsen envisions a 2021 which will surpass the era before hell broke loose starting with the hacker attack, and followed up by Covid-19 which has cost the company dearly.

Demant President & CEO Søren Nielsen. | Photo: Kenneth Lysbjerg Koustrup/Jyllands-Posten/Ritzau Scanpix

In the last couple of years, the role of CEO of Danish hearing aid giant Demant has been no walk in the park. First, a devastating hacker attack struck in September 2019, which cost the firm more than DKK 500m (USD 81.3m), after which the Covid-19 pandemic entered scene and put a spanner in the works of Demant's product sales in 2020.

"We've been through a challenging period of time. No doubt about it," Demant President & CEO Søren Nielsen tells MedWatch.

Already a subscriber? Log in.

Read the whole article

Get access for 14 days for free.
No credit card is needed, and you will not be automatically signed up for a paid subscription after the free trial.

  • Access all locked articles
  • Receive our daily newsletters
  • Access our app
An error has occured. Please try again later.

Get full access for you and your coworkers.

Start a free company trial today

More from MedWatch

CHMP to remove 100 generic medicines from market

Due to fraudulent clinical trials from a contract research organization, the EMA’s expert committee, the CHMP, is now suspending marketing approval authorizations for around 100 generic drugs on the market.

Further reading

Related articles

Latest news

See all jobs